With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

Steep cuts at the Food and Drug Administration might slow down drug approvals vital to the biopharma industry.

With expertise in pharmaceutical supply chains and medical technology, healthcare CEO and entrepreneur Dr. Jay Bhaumik has ...

Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...

After months of back and forth and uncertainty related to efforts under the new Trump Administration to reduce the size of the federal ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

The U.S. Department of Health and Human Services announced it will cut about 10,000 full-time employees in accordance with an ...

Around 3,500 employees are on the chopping block at the Food and Drug Administration, but they don’t yet know who they are.

Dr. Martin Makary has been confirmed by the Senate as the next commissioner of the Food and Drug Administration (FDA). Dr. Makary is taking the ...

Robert F. Kennedy Jr.'s overhaul of federal health agencies will likely impact how Americans get health care, prescription drugs and more.

Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet ...